REGISTERED
on 24 Dec 2024
Last Applicant/ Owned by
9 Sniffen Court
New York
NY
10016
Serial Number
88624847 filed on 20th Sep 2019
Registration Number
7626610 registered on 24th Dec 2024
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
EXCALIBUR PHARMACEUTICALS
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of fibrosis, cirrhosis, liver disease, kidney disease, dermatological conditions and diseases, autoimmune diseases, inflammatory diseases, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), and Capsular contracture; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the t Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of fibrosis, cirrhosis, liver disease, kidney disease, dermatological conditions and diseases, autoimmune diseases, inflammatory diseases, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), and Capsular contracture; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of fibrosis, cirrhosis, liver disease, kidney disease, dermatological conditions and diseases, autoimmune diseases, inflammatory diseases, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), and Capsular contracture; none of the foregoing for or related to the treatment of male erectile dysfunction
First Use Date in General
08th Feb 2022
First Use Date in Commerce
08th Feb 2022
Mark Details
Serial Number
No 88624847
Mark Type
No Service/Collective Mark
Attorney Docket Number
No C16032000000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Dec 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th Dec 2024 | REGISTERED-PRINCIPAL REGISTER |
| 05th Dec 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 05th Dec 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 04th Nov 2024 | ASSIGNED TO LIE |
| 04th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 04th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 08th Aug 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 08th May 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 08th May 2024 | NON-FINAL ACTION E-MAILED |